Dr. De Giorgi received his PhD in Medical Sciences from the Medical University of Gdansk in Poland, in partnership with the University of Milano-Bicocca in Italy. He performed his postdoctoral studies in lipid metabolism and gene therapy at Baylor College of Medicine in Houston, where he is currently an Assistant Professor.

I am a molecular and vascular biologist specializing in liver heterogeneity, with a broad background in biology and bioinformatics. My research focuses on understanding the molecular mechanisms that regulate vascular fate, endothelial cell identity, and vascular adaptability, and how these processes influence liver homeostasis. By investigating these mechanisms, my work aims to advance the field of Vascular Medicine and uncover new therapeutic opportunities.

I am a practicing transplant hepatologist and gastroenterologist with interests in clinical informatics and using technology to augment healthcare and health education, the promotion of health equity amongst learners and patients. I also have a special interest in liver diseases in pregnancy and women's liver health.

Mandana Khalili, MD, MAS is a Professor of Medicine at University of California San Francisco (UCSF) and the Director of Clinical and Translational Research in Hepatology and Chief of Clinical Hepatology at UCSF/San Francisco General Hospital. Her research focuses on addressing epidemiology, systemic complications and outcomes, novel therapies, and health policy related to viral hepatitis, steatotic liver disease (metabolic dysfunction-associated and alcohol related), cirrhosis and liver cancer.

Dr. Rohit Loomba is a Professor of Medicine (with tenure), Chief, Division of Gastroenterology and Hepatology, at the University of California at San Diego. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic steatohepatitis (NASH), and non-invasive assessment of liver disease using advanced imaging modalities.

Dr. Sujit V. Janardhan is currently an Assistant Professor of Medicine in the section of Hepatology at Rush University Medical Center in Chicago, IL. He completed his medical training, PhD in immunology residency in internal medicine and fellowship in gastroenterology and hepatology at the University of Chicago. He is board certified in Internal Medicine, Gastroenterology and Obesity medicine.

Dr. Banrida Wahlang is an Assistant Professor at the University of Louisville School of Medicine and a board-certified toxicologist (DABT). Her research program focuses on the mechanistic and translational toxicology of environmental contaminants and their role in liver disease with emphasis on sex-specific mechanisms and endocrine-metabolic disruption.

Dr. Frederick Adams Ekuban is an Assistant Professor of Medicine in the Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition at the University of Louisville School of Medicine. His research program in environmental health and toxicology focuses on elucidating the molecular mechanisms by which environmental pollutants, particularly per- and polyfluoroalkyl substances (PFAS), interact with lifestyle factors to promote liver disease.

Dr. Beier's research focuses on the interaction between environmental toxicants and metabolic liver diseases. Her work on vinyl chloride has contributed significantly to our understanding of how environmental chemicals modify liver disease risk, particularly in the context of MASLD/MASH and hepatocellular carcinoma.